Delaware | 001-38076 | 42-1775077 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
31910 Del Obispo Street Suite 200 San Juan Capistrano, California | 92675 | |||
(Address of principal executive offices) | (Zip Code) |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4c) |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒ |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Common Stock, par value $0.01 per share | EEX | New York Stock Exchange |
Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On May 22, 2019, the Board of Directors (the “Board”) of Emerald Expositions Events, Inc. (the “Company”) appointed Brian Field as Chief Operating Officer of the Company and its subsidiaries, effective June 1, 2019.
Mr. Field, 51, brings more than 20 years of experience, including the last five years as Chief Operating Officer of UBM Americas, a division of UBM plc, now part of Informa plc, a U.K.-based multinational events, academic publishing and business intelligence business, where Mr. Field had responsibilities over sales, marketing operations, data services, and creative services. Mr. Field has deep experience in B2B and B2C industries, including in healthcare information, life sciences, digital media and expositions. Prior to UBM Americas, he served two years as Managing Director of the healthcare/life-sciences division of that business, UBM Medica, and, prior to that, one year as SVP of Product and Operations. Earlier in his career, Mr. Field held senior positions in operations, product development, marketing and strategy development, serving as acting COO of the New Products Group of Turner Broadcasting, Inc, and as a senior marketing strategist in a division of Omnicom.
Mr. Field holds a bachelor’s degree from Connecticut College, a master’s degree from The Juilliard School, and a doctorate degree from Columbia University, and has served on the faculty of American University’s Kogod School of Business.
There are no related person transactions (or proposed related person transactions) with respect to Mr. Field reportable under Item 5.02(c) of Form 8-K and Item 404(a) of Regulation S-K since the beginning of the Company’s last fiscal year. There are no family relationships to disclose with respect to Mr. Field reportable under Item 401(d) of Regulation S-K.
Mr. Field will enter into the Company’s standard form of indemnification agreement, pursuant to which the Company agrees to indemnify its directors and officers to the fullest extent permitted by applicable law and, subject to certain conditions, to advance expenses in connection with proceedings as described in the indemnification agreement.
60/90 Trading Day Closing Share Price (Vesting Thresholds) | Award Value |
At least $18.00 per Share | $410,000 |
At least $20.00 per Share | $615,000 |
At least $22.00 per Share | $820,000 |
At least $24.00 per Share | $1,025,000 |
Item 7.01 | Regulation FD Disclosure. |
Item 9.01 | Financial Statements and Exhibits. |
Exhibit No. | Description |
Date: May 29, 2019 | EMERALD EXPOSITIONS EVENTS, INC. | |||||
By: | /s/ David Gosling | |||||
David Gosling | ||||||
Senior Vice President, General Counsel and Secretary |